pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
umbilical cord blood (hUCB) cells
Phase 2 · mab · Cerebral Palsy
umbilical cord blood (hUCB) cells for Cerebral Palsy is a Phase 2 program (mab) at S.L with 1 ClinicalTrials.gov record(s).
Internal code HSC-MS-12-0876
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 2
- Modality
- mab
- Indication
- Cerebral Palsy
- Status
- completed
- Trials
- 1